If numbness or tingling persists or becomes bothersome, users should consider consulting with a healthcare provider to discuss their symptoms and possibly adjust their dosage
When you're dealing with dosages measured in single milligrams, any deviation in the product's quality can have a catastrophic impact on your results
Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling
A multidisciplinary team led by Prof Eric Wan Yuk-fai analysed realworld data from Hong Kong, the UK and Japan, showing that statins reduce cardiovascular disease risk without increasing major adverse events in groups often underrepresented in trialsincluding people with type 1 diabetes, kidney failure, and older adults with chronic kidney disease
Choosing between semaglutide and tirzepatide is exactly the kind of decision that deserves a real conversation with a caring medical team one that looks at your history, your goals, and your budget, and helps you move forward safely
The labeling update underscores the importance of close monitoring as regulators continue evaluating the therapys benefit-risk profile in clinical use
